Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

She Let ChatGPT Train Her for the NYC Marathon—Here’s What Happened When AI Became the Coach

by Team Lumida
November 18, 2025
in Health and Longevity
Reading Time: 4 mins read
A A
0
pair of blue-and-white Adidas running shoes

Photo by sporlab on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • A WSJ reporter used ChatGPT as her sole marathon coach for 16 weeks, relying on it for pacing, nutrition, gear, strength work, and recovery.
  • The experience yielded mixed results: periods of strong performance—but also anxiety, bad advice, and signs of overdependence on AI.
  • Human coaches emphasize simplicity and intuition, highlighting a key gap: AI can provide data, but not judgment, reassurance, or real coaching wisdom.
  • The experiment underscores the limits of AI in high-stakes physical training: it can guide, but it cannot replace human expertise.

What Happened?

WSJ reporter Isabelle Bousquette decided to train for the New York City Marathon using ChatGPT as her full-time coach. The AI built a 16-week personalized plan based on her fitness level and goals, giving guidance on pacing, hydration, gear, nutrition, playlists, and injury prevention. She adhered closely to its recommendations—uploading Strava data, buying AI-recommended gear, and following its meal and fueling strategies. While early training went well and she achieved faster paces than in prior years, inconsistencies emerged: unrealistic playlists, questionable training structure, and growing anxiety as race day approached. Other AI tools suggested she should have trained more, adding to her doubts.


Why It Matters?

The experiment highlights the real limitations of generative AI in domains that require experience, intuition, and emotional support. Marathon coaching involves more than data; it requires tailoring intensity, reading subtle signs of fatigue, and providing confidence when athletes feel doubt. ChatGPT could optimize inputs, but it couldn’t assess her emotional state, correct overtraining risk, or provide meaningful reassurance. Even when its advice mirrored expert guidance, it lacked credibility because athletes trust human judgment over algorithmic generalities. The broader implication: AI excels at structure, personalization, and information—but cannot replicate the nuance of human coaching in physical performance.


What’s Next?

As runners increasingly use AI tools for training, hybrid models—AI convenience plus human oversight—are likely to emerge as the safest and most effective approach. Wearable integrations will improve AI personalization, but human coaches will remain crucial for reading emotional cues, managing fear of injury, and preventing overtraining. For consumer AI companies, this underscores a major opportunity: pairing AI-generated plans with human expertise. For athletes, the takeaway is clear: use AI as a tool, not a replacement. On race day, Isabelle ultimately chose to rely not on the chatbot’s logic, but on a human coach’s simple reminder—“Running is just running.”

Source
Previous Post

Bitcoin ETF Boom Turns Sour as Prices Fall Below Investors’ $89,600 Break-Even Level

Next Post

Wall Street on Edge as Nvidia Earnings and Delayed Jobs Report Set the Tone for Markets

Recommended For You

U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

by Team Lumida
1 hour ago
U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

Key takeaways Powered by lumidawealth.com U.S. life expectancy rose to 79 years in 2024, the highest on record, up 0.6 years YoY Drug-overdose deaths fell more than 26%, the...

Read more

Longevity Hacks Go Data-Driven as Preventive Health Becomes a Scalable Growth Market

by Team Lumida
1 day ago
man running on road near grass field

Key takeaways Powered by lumidawealth.com Longevity is shifting from wellness trends to measurable, science-backed health optimization Simple behaviors like strength training, protein intake, sleep consistency, and fasting windows show...

Read more

Preventive Health and Aging Tech Emerge as the Next Major Growth Market

by Team Lumida
2 days ago
black and red cherries on white bowl

Key takeaways Powered by lumidawealth.com Longevity is moving from niche wellness to a core healthcare and investment theme, powered by aging demographics and tech-driven prevention Breakthroughs in early diagnostics,...

Read more

Cancer Survivors Face Growing Risk of Heart Damage from Life-Saving Treatments

by Team Lumida
6 days ago
Cancer Survivors Face Growing Risk of Heart Damage from Life-Saving Treatments

Key Takeaways Powered by lumidawealth.com Advances in cancer treatments are leading to more survivors, but many face delayed heart damage from therapies. Modern treatments like immune checkpoint inhibitors and...

Read more

Sleep Regularity Is the Longevity Edge Most People Ignore

by Team Lumida
1 week ago
woman sleeping on bed under blankets

Key takeaways Powered by lumidawealth.com Sleep regularity (same bedtime/wake time) often matters as much as total hours for metabolic and cardiovascular health. Big swings in sleep timing can impair...

Read more

Longevity Moves From Lifestyle Trend to Investable Theme as Aging Demographics Drive Demand

by Team Lumida
1 week ago
diagram

Key takeaways Powered by lumidawealth.com Aging demographics are accelerating demand for therapies and services that extend healthspan, not just lifespan. Capital is shifting from reactive care to prevention, chronic-disease...

Read more

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

by Team Lumida
1 week ago
Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Key takeaways Powered by lumidawealth.com Metformin is a low-cost, widely prescribed diabetes drug being studied for whether it can delay age-related disease beyond glucose control. The core debate: strong...

Read more

Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

by Team Lumida
1 week ago
Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

Key takeaways Powered by lumidawealth.com Rapamycin (sirolimus) has some of the strongest preclinical longevity evidence, but human data is still early and fragmented. The core investment challenge is translation...

Read more

GLP-1s Are Becoming the First “Longevity Drug” With Real-World Outcomes Data

by Team Lumida
2 weeks ago
GLP-1s Are Becoming the First “Longevity Drug” With Real-World Outcomes Data

Key takeaways Powered by lumidawealth.com GLP-1 drugs are shifting from “weight-loss meds” to risk-reduction platforms, with evidence supporting meaningful improvements in cardiometabolic outcomes in obese/overweight populations. The investable story...

Read more

Wearable Health Devices: Helpful or Harmful to Our Well-Being?

by Team Lumida
3 weeks ago
Wearable Health Devices: Helpful or Harmful to Our Well-Being?

Key Takeaways: Powered by lumidawealth.com Wearable devices like the Oura Ring and Apple Watch have become essential tools for tracking health metrics such as sleep and heart rate. While...

Read more
Next Post
Nvidia Loses $220 Billion: What It Means for Your Investments

Wall Street on Edge as Nvidia Earnings and Delayed Jobs Report Set the Tone for Markets

Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Leverage Turns Lethal: Crypto’s Debt-Fueled Rally Now Magnifies Investor Losses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Nvidia CEO Reveals Secrets Behind AI Domination Amidst Fierce Competition

Nvidia Stock Gains Momentum Ahead of CEO’s January Keynote, New Product Launches

December 24, 2024
a bitcoin sitting on top of a pile of money

How the U.S. Election Could Make or Break Bitcoin

July 30, 2024
Cambricon’s Sales Soar 14x as Nvidia Is Shut Out

Cambricon’s Sales Soar 14x as Nvidia Is Shut Out

October 20, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018